3 Longevity Drugs I QUIT (And the 4 I Take Instead) : 1529

The 3 "Longevity Drugs" That Fail the Data, and 4 Repurposed Ones Worth Considering 

Back with another solo episode, this one on Big Pharma! Metformin, rapamycin, and statins are three of the most trusted names in longevity, and none of them hold up the way you've been told. This episode breaks down the human data behind the drugs everyone assumes are safe, and reveals four lesser-known repurposed pharmaceuticals that might do more for your metabolism, mitochondria, and lifespan. 

Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR 

Dave walks through why metformin blunts the muscle-building signal your body needs from exercise, why rapamycin's stunning mouse studies fell apart in the 2025 PEARL trial, and why statins help one person in a hundred while draining the CoQ10 your mitochondria depend on. Then he lays out the yes list: tadalafil for vascular and brain health, SGLT2 inhibitors for metabolic and kidney protection, acarbose for gut and longevity markers, and low dose naltrexone for calming an overactive immune system. 

Host Dave Asprey is the father of biohacking, founder of Danger Coffee and Smarter Not Harder, and a New York Times bestselling author who has spent decades studying human performance, functional medicine, and the science of not aging. As co-founder of Unlimited.Life, a concierge longevity practice that runs over $50,000 in lab work per client, he pulls back the curtain on what the data actually shows once you strip away the marketing. 

This is essential listening for anyone serious about biohacking, longevity, anti-aging, human performance, brain optimization, and hacking their own biology with real supplements and functional medicine tools instead of guesswork. 

You'll Learn: 

• Why metformin can cancel out the muscle gains from resistance training and drain your B12 for years 
• What the 2025 PEARL trial actually found when rapamycin was tested in healthy adults 
• Why statins carry a 100-to-1 harm-to-benefit ratio and quietly starve your mitochondria of CoQ10 
• How tadalafil supports nitric oxide, vascular health, and neuroplasticity at low daily doses 
• Why SGLT2 inhibitors trigger ketosis-like metabolic effects and protect kidney function 
• How acarbose changes gut bacteria and shows some of the strongest longevity data in mouse studies 
• How low dose naltrexone modulates the immune system and reduces neuroinflammation 
• How to talk to your doctor about using these drugs off-label for longevity instead of disease treatment 

Thank you to our sponsors!      

- ALP | Go to alppouch.com, code DAVE for 10% off. 

- Timeline | Visit timeline.com/dave and get up to 20% off when you subscribe and save. 

- Kinetic | Instead of pushing your system harder, Kenetik feeds your brain the ketones it craves to fuel calm clarity and steady focus. Go to drinkkenetik.com/DAVE and use code DAVE for a discount. 

- Visit www.myvitalc.com/davesfav to unlock Dave’s discount 

Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights inhealth, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. 

New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. 

Keywords: Metformin, Rapamycin, Statins, Tadalafil, Cialis, SGLT2 inhibitors, Jardiance, Acarbose, low dose naltrexone, longevity drugs, anti-aging medication, repurposed pharmaceuticals, off-label drugs, mTOR inhibitor, AMPK, autophagy, endothelial dysfunction, CoQ10, insulin resistance, mitochondrial efficiency, senescent cells, nitric oxide, neuroinflammation, vascular health, PEARL trial, Unlimited.Life 

Resources:   

• Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/  

• Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today.   

• Danger Coffee: https://dangercoffee.com/discount/dave15? 

• My Daily Supplements: SuppGrade Labs (15% Off)    

• Favorite Blue Light Blocking Glasses: TrueDark (15% Off)    

• Dave Asprey’s BEYOND Conference: https://beyondconference.com    

• Dave Asprey’s New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated   

• Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/  

• Upgrade Labs: https://upgradelabs.com    

Timestamps:  

00:00 – Trailer 

01:01 – Intro 

03:48 – Metformin 

09:18 – Rapamycin 

12:55 – Statins 

17:28 – Statins & CoQ10 

19:38 – Tadalafil 

23:43 – SGLT2 Inhibitors 

26:12 – Acarbose 

28:40 – Low-Dose Naltrexone (LDN) 

31:44 – Dosing & Recap 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.